Actinium Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $17.4M | $20.5M | $25.6M | $6.7M | $5.5M | $5.6M | $5.7M | $196.1K |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $17.8M | $22.4M | $26.5M | $7.4M | $5.8M | $5.8M | $6.2M | $150 |
| Property, Plant & Equipment | $57.4K | $88.5K | $106.1K | $127.7K | $13.9K | $3.0K | $1.2K | $0 |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $18.3M | $22.5M | $26.6M | $7.6M | $5.8M | $5.8M | $6.2M | $150 |
| Liabilities | ||||||||
| Accounts Payable | $4.7M | $4.2M | $1.5M | $2.3M | $379.0K | — | $6 | $13.7K |
| Total Current Liabilities | $4.7M | $4.5M | $4.6M | $9.5M | $7.3M | $4.6M | $5.2M | $36.1K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $4.7M | $4.5M | $4.6M | $9.5M | $7.3M | $4.6M | $84.5K | $94.8K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-163.2M | $-136.6M | $-112.2M | $-91.2M | $-66.5M | $55.7M | $-259.8K | $-270.1K |
| Total Stockholders' Equity | $13.7M | $18.0M | $22.0M | $-1.9M | $-1.6M | $1.1M | $992.0K | $399.1K |